Research Groups and R&D Platforms: Biopharmaceuticals

Picture of Stefan Willför

Research Group:
Valorisation of biomass using molecular process technology

Stefan Willför
swillfor[at]abo.fi

Laboratory of Wood and Paper Chemistry,
Åbo Akademi University

Stefan Willför

PCC

Antibacterial, Biopharmaceuticals, Diagnostics, Drug solubility, Drug stability, Electron microscopy, Hit to lead, MALS or SEC-MALS, Natural Compounds, Natural products, NMR, Organic Chemistry, Organic compounds, Particle size analysis, Personalized medicine, Physico-chemical properties, Porosity, Surface area, Synthetic chemistry, Thermal analysis

Research Group:
Glycolipids and glycoproteins as cell adhesion receptors

Sauli Haataja
sauli.haataja[at]utu.fi

Institute of Biomedicine,
University of Turku

Sauli Haataja

Antibacterial, Antibodies, Assay development, Bacteriology, Basic research, Biochemistry, Bioinformatics, Biomedicine, Biomolecular chemistry, Biopharmaceuticals, Biotechnology, Cancer, Electron microscopy, Genetics, Genomics, Imaging, Infection, Inflammation, Molecular Biology, Molecular Cell Biology, Molecular modelling, Nanoparticles, Natural Compounds, Natural products, Next-generation sequencing, Proteomics, Receptor, Screening, Signaling, Structural Biology, Synthetic chemistry, Systems Biology, Target discovery, X-ray crystallography

Picture of Reko Leino

Research Group:
Synthetic chemistry and chemical biology

Reko Leino
reko.leino[at]abo.fi

Laboratory of Organic Chemistry,
Åbo Akademi University

Reko Leino

PCC

Allergy, Asthma, Autoimmune diseases, Biomedicine, Biomolecular chemistry, Biopharmaceuticals, Cancer, Drug delivery, Fluorescence spectroscopy, Hit to lead, Immunology, Infection, Inflammation, Lead optimization, Medicinal chemistry, Melanoma, Molecular modelling, Natural Compounds, Natural products, NMR, Organic Chemistry, Organic compounds, PET, Powder X-ray diffraction, Screening, Skin diseases, Synthetic chemistry, Thermal analysis, X-ray crystallography

Research Group:
Imaging Alzheimer’s disease beta-amyloid pathology in transgenic mouse models using positron emission tomography

Francisco López-Picón
fralop[at]utu.fi

Turku PET Centre, Preclinical Imaging,
University of Turku

Francisco López-Picón

Turku PET Centre

Ageing-related diseases, Biomarker, Biomedicine, Biopharmaceuticals, Clinical Medicine, Disease models, Drug delivery, Drug target, Epigenomics, Imaging, Imaging software, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Molecular Biology, Molecular diagnostics, Neurological disorders, Pathology, PET, Pharmacology, Physiology, Preclinical development, Proteomics, Target discovery

Picture of Mark S. Johnson

Research Group:
Structural bioinformatics for drug discovery and development

Mark S. Johnson
finmark54 at icloud dot com

Biochemistry,
Åbo Akademi University

Mark S. Johnson

Structural Bioinformatics Laboratory

Ageing-related diseases, Autoimmune diseases, Basic research, Biochemistry, Bioinformatics, Biomolecular chemistry, Biopharmaceuticals, Biotechnology, Cancer, Chemical Physics, Computer Science, Diabetes, Drug target, Hit to lead, Inflammation, Inherited diseases, Lead optimization, Lung cancer, Medicinal chemistry, Metabolic diseases, Molecular modelling, Musculoskeletal disorders, Nucleic acids, Organic compounds, Pattern recognition, Personalized medicine, Physico-chemical properties, Preclinical development, Receptor, Signaling, Structural Biology, Surface area, Target discovery, X-ray crystallography

Research Group:
Biomaterials for controlled delivery of drugs and antigens and for tissue engineering

Mika Jokinen
mika.jokinen[at]turkuamk.fi

Chemical Engineering / Biomaterials & Diagnostics,
Turku University of Applied Sciences

New Materials and Processes

Uudet materiaalit ja prosessit

Biopharmaceuticals, Biotechnology, Diagnostics, Drug delivery, Fluorescence spectroscopy, Formulation, FTIR or RAMAN spectroscopy, In Vitro Diagnostics, Particle size analysis, Physico-chemical properties, Preclinical development